IL-12Rβ2 is a common receptor subunit of heterodimeric receptors for IL-12 and IL-35, two cytokines that are implicated in immunopathogenesis of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. We evaluated the role of IL-12Rβ2 in relapsing-remitting EAE (RR-EAE). IL-12Rβ2-deficient SJL/J mice developed markedly more severe clinical EAE, and had greater mortality and more severe relapses compared with wild-type controls. IL-12Rβ2-deficient EAE mice also had more infiltrating mononuclear cells in the CNS, as well as higher T cell proliferative capacity and decreased IFN-γ production at the periphery. These findings demonstrate a protective role of IL-12Rβ2 in RR-EAE.
Introduction
Experimental autoimmune encephalomyelitis (EAE), 2 an animal model of multiple sclerosis (MS), is a CD4 + T cell-mediated autoimmune disease (Noseworthy et al., 2000) . In 2003, Cua et al. demonstrated that IL-23, but not IL-12, plays an essential role in EAE development (Cua et al., 2003) . This finding dispelled the long-held view that IL-12 is critical to the development of EAE and called for a re-evaluation of its role in autoimmune inflammation of the central nervous system (CNS). Members of the IL-12 family of cytokines and their corresponding receptors are both heterodimers that share common cytokine and receptor subunits. IL-12 is a covalent heterodimer of IL-12p40 and IL-12p35 subunits, which form the complete cytokine IL-12p70 (Trinchieri, 1998) . IL-23 is comprised of covalently bound IL-12p40 and IL-23p19 (Oppmann et al., 2000) ; IL12p40 is therefore a common subunit between IL-12 and IL-23. IL-12 exerts its effects through its receptor (IL-12R), which is comprised of two chains, IL-12Rβ1 and IL-12Rβ2 (Chua et al., 1995) . While the IL-12Rβ1 subunit is constitutively expressed by naïve CD4 + T cells (Chang et al., 1999) , the expression of IL-12Rβ2 is upregulated upon activation of naïve T cells that develop into Th1 and Th17 cells (Lexberg et al., 2010; Szabo et al., 1997) . In addition to comprising IL-12R, both of its subunits are also involved in the formation of receptors for two other cytokines; IL-12Rβ1 is part of the IL-23 receptor heterodimer (Oppmann et al., 2000) , while IL-12Rβ2 also participates in the receptor for IL-35. IL-35 is a non-covalent heterodimer of IL-12p35 and EpsteinBarr-virus-induced gene 3 (EBI3) (Collison et al., 2007) , which together with IL-27p28 also forms IL-27 (Pflanz et al., 2002) . The molecular composition of the members of the IL-12 family of cytokines and their receptors is schematically shown in Supplemental Fig. 1 . Factors that determine various disease courses in MS and EAE are not well understood, but it is apparent that clinical disease courses in relapsing-remitting (RR) and progressive MS/EAE are governed by different mechanisms. MOG 35-55 -induced EAE in C57BL/6 mice has a chronic disease course, but the majority of MS patients (~85%) develop RR disease (Compston and Coles, 2008) , and EAE models that have a RR clinical course are likely better suited for studying immunopathogenic mechanisms of RR-MS. The most commonly used RR-EAE model is in SJL/J mice immunized with PLP 139-151 peptide (Furlan et al., 2009 ). Histopathologically and clinically, this model is similar to the RR form of MS.
Given that both IL-12 subunits and both IL-12R subunits are shared with other cytokines and their receptors, it has been difficult to devise an approach that would in vivo solely address the role of IL-12, and the same is true for IL-35. The most relevant findings on the role of IL-12Rβ2 in EAE come from a study with IL-12Rβ2 −/− C57BL/6 mice.
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